Fibroblast-Derived Decellularized Extracellular Matrix as a Bioactive Substrate for Osteoblast Activation

Area of Science:

• Biomaterials Science
• Cell Biology
• Tissue Engineering

Background:

• The extracellular matrix (ECM) is crucial for cell regulation and is utilized in biomaterial design.
• Reproducible generation of cell-derived ECM is hindered by decellularization method variability.
• Fibroblast-derived ECM holds potential for regenerative medicine applications.

Purpose of the Study:

• To refine a detergent-based protocol for producing fibroblast-derived ECM with improved DNA removal and preserved protein content.
• To evaluate the effects of this refined cell-derived ECM on primary human osteoblast (HOB) behavior and osteogenic differentiation.

Main Methods:

• A detergent-based protocol was modified for fibroblast-derived ECM preparation.
• DNA removal efficiency and protein content were assessed.
• Proteomic analysis provided contextual reference.
• Functional assays evaluated HOB responses to varying ECM concentrations.

Main Results:

• The refined protocol achieved up to 98.3% DNA removal while preserving protein content.
• Fibroblast-derived ECM at 1.25 mg/mL increased alkaline phosphatase activity and RUNX2 levels in HOBs.
• Enhanced calcium and phosphate deposition was observed, indicating increased mineralization.

Conclusions:

• The refined fibroblast-derived ECM is a biologically active substrate that enhances osteoblast function.
• This cell-derived ECM promotes early osteogenic signaling and matrix mineralization.
• Further research is needed to fully elucidate the osteogenic potential of this biomaterial.